186086-71-5

Basic information

• Product Name: 3-PYRROLIDIN-1-YL-BENZOIC ACID METHYL ESTER
• Synonyms: METHYL 3-(PYRROLIDIN-1-YL)BENZOATE;3-PYRROLIDIN-1-YL-BENZOIC ACID METHYL ESTER;Methyl 3-(1-Pyrrolidinyl)benzoate;3-(1-pyrrolidinyl)Benzoic acid methyl ester
• CAS NO: 186086-71-5
• Molecular Formula: C₁₂H₁₅NO₂
• Molecular Weight: 205.25
• Mol File: 186086-71-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-PYRROLIDIN-1-YL-BENZOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-PYRROLIDIN-1-YL-BENZOIC ACID METHYL ESTER(186086-71-5)
• EPA Substance Registry System: 3-PYRROLIDIN-1-YL-BENZOIC ACID METHYL ESTER(186086-71-5)

Safety Data

• Hazardous Substances Data: 186086-71-5(Hazardous Substances Data)

Usage

General Description

3-Pyrrolidin-1-yl-benzoic acid methyl ester is a chemical compound that belongs to the class of pyrrolidine derivatives. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. This chemical is known for its potential anticonvulsant and anti-inflammatory properties. It can also act as a chelating agent and is used in the manufacturing of various coordination compounds. Additionally, 3-Pyrrolidin-1-yl-benzoic acid methyl ester has been studied for its potential use as a building block in organic synthesis. Overall, this chemical compound has diverse applications in the fields of pharmaceuticals, agrochemicals, and chemical research.

Upstream product

• 123-75-1 pyrrolidine 
• 618-89-3 methyl 3-bromobenzoate 
• 618-91-7 methyl 3-iodo-benzoate 
• 99-05-8 meta-aminobenzoic acid 

Downstream Products

• 859850-72-9 (3-(pyrrolidin-1-yl)phenyl)methanol 
• 72548-79-9 3-(pyrrolidin-1-yl)benzoic acid 

Relevant articles and documents

Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes

The free fatty acid receptor 1 (FFA1) has gained significant interest as a novel antidiabetic target. Most of FFA1 agonists reported in the literature bearing a common biphenyl scaffold, which was crucial for toxicity verified by the researchers of Daiichi Sankyo. Herein, we describe the systematic exploration of non-biphenyl scaffold and further chemical modification of the optimal pyrrole scaffold. All of these efforts led to the identification of compound 11 as a potent and orally bioavailable FFA1 agonist without the risk of hypoglycemia. Further molecular modeling studies promoted the understanding of ligand-binding pocket and might help to design more promising FFA1 agonists.

Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation

Methods and compounds are provided for the formation of carbon-nitrogen or carbon-carbon bonds comprising reacting an amine or an aryl boronic acid with an aryl halide in the presence of a palladium catalyst, a base, and a compound of formula II:

Application of a New Bicyclic Triaminophosphine Ligand in Pd-Catalyzed Buchwald-Hartwig Amination Reactions of Aryl Chlorides, Bromides, and Iodides

The new bicyclic triaminophosphine ligand P(i-BuNCH2) 3CMe (3) has been synthesized in three steps from commercially available materials and its efficacy in palladium-catalyzed reactions of aryl halides with an array of amines has been demonstrated. Electron-poor, electron-neutral, and electron-rich aryl bromides, chlorides, and iodides participated in the process. The reactions encompassed aromatic amines (primary or secondary) and secondary amines (cyclic or acyclic). It has also been shown that the weak base Cs2CO3 can be employed with ligand 3, allowing a variety of functionalized substrates (e.g., those containing esters and nitro groups) to be utilized in our amination protocols. This ligand provides a remarkably general, efficient, and mild palladium catalyst for aryl iodide amination. Although 3 is slightly air and moisture sensitive, easy procedures can be adopted that avoid the need of a glovebox. Comparisons of the efficacy of 3 in these reactions with that of the proazaphosphatrane P(i-BuNCH2CH2)3N (2) reveal that in addition to the opportunity for transannulation in 2 (but not in 3), other significant stereoelectronic contrasts exist between these two ligands which help account for differences in the activities of the Pd/2 and Pd/3 catalytic systems.